Provided herein are novel bicyclic amines as CDK2 inhibitors, pharmaceutical compositions, use of such compounds in treating metastatic breast cancer or metastatic lung cancer and processes for ...

These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 16 substances, referred to collectively under the CMP as the Monocyclic, and ...